Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre
In spite of there being a number of vaccines, influenza remains a significant global cause of morbidity and mortality. Understanding more about natural and vaccine induced immune protection against influenza infection would help to develop better vaccines. Virus specific IgG is a known correlate of...
Main Authors: | Victoria M. W. Gould, James N. Francis, Katie J. Anderson, Bertrand Georges, Alethea V. Cope, John S. Tregoning |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmicb.2017.00900/full |
Similar Items
-
IgA Responses Following Recurrent Influenza Virus Vaccination
by: Rodrigo B. Abreu, et al.
Published: (2020-05-01) -
Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein
by: C. Joaquín Cáceres, et al.
Published: (2021-06-01) -
Differential distribution of IgA-protease genotypes in mucosal and invasive isolates of Haemophilus influenzae in Sweden
by: Fredrik Resman, et al.
Published: (2018-11-01) -
IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
by: Oka K, et al.
Published: (2016-11-01) -
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
by: Isabella Quinti, et al.
Published: (2021-04-01)